← Open Payments lookup

JENNIFER BAILEY: Open Payments

NPI 1114705829 · ST. PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,064 in 348 payments from 14 companies in 2025. Trend: 2023 $54 · 2024 $1,878 · 2025 $4,064

Food & beverage: $3,952Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.122$876
Teva Pharmaceuticals USA, Inc.86$668
ABBVIE INC.25$413
Alkermes, Inc.20$406
E.R. Squibb & Sons, L.L.C.23$386
Janssen Pharmaceuticals, Inc16$316
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$299
Otsuka America Pharmaceutical, Inc.15$231
Takeda Pharmaceuticals U.S.A., Inc.10$184
Luye Pharma (USA) Ltd.5$131

Products named: INGREZZA, VRAYLAR, COBENFY, AUSTEDO XR, ARISTADA, INVEGA, CAPLYTA, UZEDY.

Industry payments across FL — which companies pay providers there.